# P3 Health Partners

> P3 Health Partners is a physician-founded population health management company that helps primary care practices coordinate care, manage Medicare risk and reduce administrative work. Its affiliate model connects existing community providers with clinical support, data and health-plan contracting, earning mainly fixed monthly payments while taking responsibility for covered medical costs.

- **Founded:** 2017
- **Headquarters:** Henderson, United States
- **Founders:** Sherif Abdou (Co-founder and founding CEO), Amir Bacchus (Co-founder and founding Chief Medical Officer)
- **Products:** P3 Care Model, Provider support, Health-plan delegated services, P3 Health Hub, ACO joint venture management services
- **Notable:** Began commercial operations in April 2017; first at-risk contract effective January 2018., Completed the Foresight business combination in December 2021 and became publicly traded., Announced inclusion in the Russell 3000 Index in June 2022, a historical milestone.

## Products & services

- **P3 Care Model** — Education, prevention, medication support, nursing, community resources and transitions between care settings.
- **Provider support** — Local clinical teams, practice support, patient outreach, network contracting and actionable patient data.
- **Health-plan delegated services** — Network, utilization, quality, care and medical management, plus claims processing where delegated.
- **P3 Health Hub** — A proprietary system supporting aggregation and analysis of third-party data for care management.
- **ACO joint venture management services** — Majority-owned joint venture with Commonwealth Primary Care ACO sharing operations while ACO entities remain independent.

## Achievements

- Began commercial operations in April 2017; first at-risk contract effective January 2018.
- Completed the Foresight business combination in December 2021 and became publicly traded.
- Announced inclusion in the Russell 3000 Index in June 2022, a historical milestone.
- Reported consolidated net income of $15.7 million in Q2 2026; favorable settlements and prior-period development contributed to results.

## Latest updates

- **2026-10** — Appointed Dr. Michael Millie Chief Clinical Officer, effective October 12.
- **2026-10** — On October 22, scheduled Q3 2026 results and conference call for November 9, 2026.
- **2026-08** — Reported Q2 revenue of approximately $386 million and raised full-year adjusted EBITDA guidance to $80 million-$110 million; adjusted EBITDA is non-GAAP.

## Links

- Website: https://p3hp.org/
- LinkedIn: https://www.linkedin.com/company/p3-health-group
- Twitter/X: https://twitter.com/P3HP_PIII
- Instagram: https://www.instagram.com/p3healthpartners/
- Facebook: https://www.facebook.com/p3healthpartners/

---

Profile page: https://yespress.io/p3-health-partners
Published by YesPress — https://yespress.io
Last updated: 2026-10-24